Overview

Post Marketing Surveillance Study of Cuprimine

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Penicillamine